Evidence map›Paper›PMID 42429877›Full record

ReviewMolecular biology reports2026

Research progress on VDAC2 in mitochondrial dysfunction-related diseases.

Miao Wang, Yuanyuan Cui, Yili Sun, Jia Li

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Miao WangSchool of Pharmacy, Shandong Medical And Pharmaceutical University, Yantai, 264003, China.
Yuanyuan CuiShandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, 264117, China.
Yili SunShandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, 264117, China. yilisun@simm.ac.cn.
Jia LiSchool of Pharmacy, Shandong Medical And Pharmaceutical University, Yantai, 264003, China. jli@simm.ac.cn.

Funding

Innovative Drug Research and Development National Science and Technology Major Project 2025ZD1800700Key R&D Program of Shandong Province, China 2024CXPT028National Natural Science Foundation of China 82570641Natural Science Foundation of Shanghai Municipality 24ZR1477400Shandong Provincial Natural Science Foundation ZR2024QC286Taishan Scholar Foundation of Shandong Province tstp0648
6 · The paper itself

Abstract

Mitochondrial dysfunction contributes to numerous human diseases. Voltage‑dependent anion channel 2 (VDAC2) is an essential outer mitochondrial membrane porin with distinct structural and functional properties that are non-redundant with those of VDAC1 and VDAC3. VDAC2 precisely controls ATP, ADP, NADPH and Ca

Indexed as

MitochondriaMitochondrial DiseasesVoltage-Dependent Anion Channel 2AnimalsApoptosisHumansNeurodegenerative DiseasesVDAC2 protein, humanVoltage-Dependent Anion Channel 2ApoptosisMitochondrial dysfunctionMyocardial injuryNeurodegenerative diseasesTumorVDAC2

Identifiers

PMID42429877

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.